Personality changes during antidepressant treatment

Psychiatria Danubina

Volumn 21, Issue 1, 2009, Pages 25-32

  Hruby, Radovan ^a   Nosalova, Gabriela ^a   Ondrejka, Igor ^a   Preiss, Marek ^b  

^a University Hospital in Martin   (Slovakia)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

Antidepressant; Character; Depression; Temperament; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CHARACTER; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HARM REDUCTION; HUMAN; MALE; MIXED ANXIETY AND DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTPATIENT; PERSONALITY DISORDER; PSYCHOLOGICAL RATING SCALE; RECURRENT DISEASE; SELF TRANSCENDENCE; TEMPERAMENT AND CHARACTER INVENTORY; TREATMENT DURATION;

ADRENERGIC UPTAKE INHIBITORS; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY DISORDERS; CHARACTER; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PSYCHOMETRICS; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; TEMPERAMENT;

EID: 63649148132     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abrams KY, Yune SK, Kim SJ, Jeon HJ, Han SO, Hwang J, Sung YH, Lee KJ & Lyoo IK: Trait and state aspects of harm avoidance and its implication for treatment in major depressive disorder, dysthymic disorder, and depressive personality disorder. Psychiatry Clin Neurosci 2004; 58: 240-8.
2. American Psychiatric Association: Practice guidelines for major depressive disorder in adults. Am J Psychiatry 1993; 150: S1-S26.
3. Brody AL, Saxena S, Fairbanks LA, Alborzian S, Demaree HA, Maidment KM & Baxter LR: Personality changes in adult subjects with major depressive disorders or obsessive-compulsive disorder treated with paroxetine. J Clin Psychiatry 2000; 61:349-55.
4. Cloninger CR: A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments 1986; 3:167-226.
5. Cloninger CR.: A svsthematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987; 44:573-88.
6. Cloninger CR: Feeling Good: the Science of Well Being. Oxford University Press: New York, 2004.
7. Cloninger CR: Bayon C & Svrakic DM: Measurement of temperament and character in mood disorders: A model of fundamental states as personality types. J Affect Disord 1998; 51:21-31.
8. Cloninger CR & Svrakic DM: 2000. Personality disorders 1723-1764. In: Kaplan and Sadock's Comprehensive Textbook of Psychiatry, Sadock BJ, Sadock VA (eds). Williams and Wilkins, Philadelphia: Lippincott, 2000.
9. Cloninger CR, Przybeck TR, Svrakic DM & Wetzel RD: The Temperament and Character Inventory (TC1): A Guide to its Development and Use. St. Louise, MO: Center for Psychobiology of Personality, 1994.
10. Enns MV & Cox BJ: Personality dimensions and depression: review and commentary. Can J Psychiatry 1997; 42:274-84.
11. Farmer A, Mahmood A, Redman K, Harris T, Sadler S & McGuffin P: A sib-pair study of the Temperament and Character Inventory scales in major depression. Arch Gen Psychiatry 2003; 60:490-96.
12. Gabbard GO: A neurobiologically informed perspective on psychotherapy. Br J Psychiat 2000; 177: 117-22.
13. Gelfin Y, Gorfine M & Lerer B: Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. Am J Psychiatry 1988; 155:290-292.
14. Gutiererrez-Zotes JA, Bayon C, Montserrat C, Valero J, Labad A & Cloninger CR: Temperament and Character Inventory Revised (TC1-R). Standardization and normative data in a general population sample. Actas Esp Psiquiatr 2004; 32:8-15.
15. Hirano S, Sato T, Narita T, Kusunoki K, Ozaki N, Kimura S, Takahashi T, Sakado K & Uehara T: Evaluating the state dependancy of the Temperament and Character Inventory Dimensions in patients with major depression: a methodological contribution. J Affect Disord 2002; 69:31-8.
16. Joffe RT, Bagby RM, Levitt AJ, Regan JJ & Parker JDA: The Tridimensional Personality Questionnaire in major depression. Am J Psychiatry 1993; 150:959-60.
17. Joyce PR., Mulder RT & Cloninger CR: Temperament predicts clomipramine and desipramine response in major depression. J Affect Disord 1994; 30:35-46.
18. Joyce PR., Mulder RT, Luty SE, McKenzie JM, Sullivan PF & Cloninger CR: Borderline personality disorder in major depression: differential drug response, and 6-month outcome. Compr Psychiatry 2003; 44:35-43.
19. Jylhä P & Isometsá E: 2006. Temperament, character and symptoms of anxiety and depression in the general population. Eur Psychiatry 2006; 21:389-395.
20. Kessler RC, Berglund P & Demler O: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
21. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC, Terpstra J, Turner RA & Reus VI: 1998. Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 1998; 155:373-79.
22. Matsudaira T & Kitamura T: Personality Traits as Risk Factors of Depression and Anxiety Among Japanese Students. J Clin Psychol 2006; 62:97-109.
23. Nelson EC & Cloninger CR: The tridimensional personality questionnaire as a predictor of reponse to nefazodone treatment of depression. J Affect Disord 1995; 35:51-7.
24. Nelson, EC & Cloninger CR: Exploring the TPQ a possible predictor of antidepressant reponse to nefazodone in a large multi-side study. J Affect Disord 1997; 44:197-200.
25. Schatzberg AF& Nemeroff ChB: Textbook of Psychopharmacology. American Psychiatric Press: Washington, 1998.
26. Tome MB, Cloninger CR, Watson JP & Isaac MT: Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality and response to paroxetine and pindolol. J Affect Disord 1997; 44:101-9.